CCCC - Company ID 0001662579
The table below shows C4 Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q1 2023 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $78.61M | $61.27M | $58.81M | $78.16M | $51.29M | $59.65M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $1.33M | $2.88M | $6.54M | $2.16M | $8.03M | $10.34M |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $262.90M |
| $245.37M |
| $206.86M |
| $224.73M |
| $232.53M |
| $273.23M |
| Property, plant & equipment | $4.15M | $4.49M | $5.13M | $5.54M | $5.48M | $6.21M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $359.40M | $328.86M | $265.49M | $296.53M | $319.52M | $376.06M |
| Accounts payable | $1.12M | $773.00K | $1.33M | $2.22M | $683.00K | $1.50M |
| Total current liabilities | $48.25M | $27.25M | $35.95M | $44.46M | $40.82M | $43.29M |
| Long-term debt | - | - | - | - | - | $0.00 |
| Total liabilities | $112.14M | $94.61M | $111.08M | $122.46M | $124.38M | $133.40M |
| Retained earnings | -$787.46M | -$763.82M | -$718.21M | -$686.04M | -$660.02M | -$599.13M |
| Total equity | $247.26M | $234.25M | $154.41M | $174.06M | $195.14M | $242.66M |